Effect of Dexmedetomedine Induced Hypotensive Anesthesia on the Haemostatic Markers.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201704002217398

Enrollment

Registered

2017-04-20

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery spine surgery

Interventions

group I

group II

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients will be included in the study if their age 18-40 and ASA I, II.

Exclusion criteria

Exclusion criteria: Exclusion criteria comprised patients with a history of blood disease, a family history of blood disorder, renal or hepatic disease. Patients will be also informed to stop aspirin or any nonsteroidal anti-inflammatory drugs 3 weeks before the operation.

Design outcomes

Primary

Measure	Time frame
Induced hypotension with mean arterial blood pressure (MAP) values of 55¿65 mm Hg reduces intraoperative blood loss and thereby optimizes surgical conditions;effect of Dexmedetomidine induced hypotensive anesthesia on platelet aggregation during surgery	—

Secondary

Measure	Time frame
effect of Dexmedetomidine induced hypotensive anesthesia on the other hemostatic markers	—

Countries

Egypt

Contacts

Public Contactgehan eid

Lecturer of Anaesthesia and and Intesive care

gehan2552011@gmail.com01287466651

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026